First in Human Study for Safety and Tolerability of AL003.
Clinical trial NCT03822208 · COMPLETED
Trial details
- NCT number
- NCT03822208
- Sponsor
- Alector Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2021-05-06
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.